|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1989-12-15
|
|
pubmed:abstractText |
Quantitation of immunohistochemical staining by image analysis was performed on 50 breast cancers stained with the monoclonal antibody Ki-67 to determine the growth fraction and its correlation with tumor grade. A high degree of correlation was shown. For each case the DNA ploidy was determined by quantitation of the DNA Feulgen stain by computerized microdensitometry. DNA content of breast tumor cells correlated to the histopathologic grade at which poorly differentiated tumors are more likely to be aneuploid. Quantitation of immunohistochemistry for estrogen and progesterone receptors had a high degree of correlation with the steroid binding assay, such as dextran-coated charcoal assay (DCCA), and were weakly correlated to histologic grade. In summary, our results indicated that quantitation of Ki-67-positive nuclear area and of DNA content by image analysis provides an objective method for assessing tumor cell growth fraction and DNA ploidy. Quantitation of steroid receptors by immunohistochemistry is a better and easier technique than those currently used to determine the best therapy for postmenopausal women. These methods can be performed on small frozen sections or needle aspirates in quantities that are insufficient for current steroid binding assays. Thus, this method is prognosticly useful even for patients with small breast lesions.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-13499785,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-213652,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2436753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2458030,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2464940,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2536520,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2536582,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2766883,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2903446,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2915655,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-2983150,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3020096,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3022849,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3052804,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3355766,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3358366,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3383134,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3582068,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3733070,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3798106,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3965140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-3971924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-4042787,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-6318957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-6339421,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-6468180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-6616406,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2817079-6690053
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0002-9440
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
135
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
783-92
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2817079-Antibodies, Monoclonal,
pubmed-meshheading:2817079-Breast Neoplasms,
pubmed-meshheading:2817079-Cell Division,
pubmed-meshheading:2817079-DNA,
pubmed-meshheading:2817079-Humans,
pubmed-meshheading:2817079-Immunohistochemistry,
pubmed-meshheading:2817079-Ploidies,
pubmed-meshheading:2817079-Receptors, Estrogen,
pubmed-meshheading:2817079-Receptors, Progesterone,
pubmed-meshheading:2817079-Tumor Markers, Biological
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Biological grading of breast cancer using antibodies to proliferating cells and other markers.
|
|
pubmed:affiliation |
Cell Analysis Systems, Inc., Lombard, IL 60148.
|
|
pubmed:publicationType |
Journal Article
|
